Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study

Sahin, T.Kemik, F.Muglu, H.Biter, S.Tunbekici, S.Oruc, A.Aksoy, S.2026-09-262026-09-2620261078-04321557-3265https://hdl.handle.net/11454/136668San Antonio Breast Cancer Symposium -- DEC 09-12, 2025 -- San Antonio, TX[No abstract available]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study - [2]Conference Object32WOS:001724426403384Q1